{"id":28757,"date":"2025-05-31T01:06:40","date_gmt":"2025-05-31T01:06:40","guid":{"rendered":"http:\/\/medexperts.pro\/?p=28757"},"modified":"2025-05-31T01:26:53","modified_gmt":"2025-05-31T01:26:53","slug":"trump-administration-ends-program-critical-to-search-for-an-h-i-v-vaccine","status":"publish","type":"post","link":"https:\/\/medexperts.pro\/?p=28757","title":{"rendered":"Trump Administration Ends Program Critical to Search for an H.I.V. Vaccine"},"content":{"rendered":"
<\/div>\n

The termination is the latest in a series of cuts to H.I.V. research and programs to prevent the disease.<\/p>\n

\n
\n
\n

The Trump administration has dealt a sharp blow to work on H.I.V. vaccines, terminating a $258 million program<\/a> whose work was instrumental to the search for a vaccine.<\/p>\n

Officials from the H.I.V. division of the National Institutes of Health delivered the news on Friday to the program\u2019s two leaders, at Duke University and the Scripps Research Institute.<\/p>\n

Both teams were collaborating with numerous other research partners. The work was broadly applicable to a wide range of treatments for other illnesses, from Covid drugs to snake antivenom<\/a> and therapies for autoimmune diseases<\/a>.<\/p>\n

\u201cThe consortia for H.I.V.\/AIDS vaccine development and immunology was reviewed by N.I.H. leadership, which does not support it moving forward,\u201d said a senior official at the agency who was not authorized to speak on the matter and asked not to be identified.<\/p>\n<\/div>\n<\/div>\n

<\/div>\n
\n
\n

\u201cN.I.H. expects to be shifting its focus toward using currently available approaches to eliminate H.I.V.\/AIDS,\u201d the official said.<\/p>\n

The program\u2019s elimination is the latest in a series of cuts to H.I.V.-related initiatives, and to prevention of the disease in particular. Separately, the N.I.H. also paused funding for a clinical trial of an H.I.V. vaccine made by Moderna.<\/p>\n

\n
\n
<\/div>\n
\n
\n
\n

We are having trouble retrieving the article content.<\/p>\n

Please enable JavaScript in your browser settings.<\/p>\n<\/div>\n<\/div>\n

\n
\n

Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into<\/a>\u00a0your Times account, or\u00a0subscribe<\/a>\u00a0for all of The Times.<\/p>\n

\n<\/div>\n
\n
\n

Thank you for your patience while we verify access.<\/p>\n

Already a subscriber?\u00a0Log in<\/a>.<\/p>\n

Want all of The Times?\u00a0Subscribe<\/a>.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

The termination is the latest in a series of cuts to H.I.V. research and programs to prevent the disease.The Trump administration has dealt a sharp blow to work on H.I.V. vaccines, terminating a $258 million program whose work was instrumental to the search for a vaccine.Officials from the H.I.V. division of the National Institutes of Health delivered the news on Friday to the program\u2019s two leaders, at Duke University and the Scripps Research Institute.Both teams were collaborating with numerous other research partners. The work was broadly applicable to a wide range of treatments for other illnesses, from Covid drugs to snake antivenom and therapies for autoimmune diseases.\u201cThe consortia for H.I.V.\/AIDS vaccine development and immunology was reviewed by N.I.H. leadership, which does not support it moving forward,\u201d said a senior official at the agency who was not authorized to speak on the matter and asked not to be identified.\u201cN.I.H. expects to be shifting its focus toward using currently available approaches to eliminate H.I.V.\/AIDS,\u201d the official said.The program\u2019s elimination is the latest in a series of cuts to H.I.V.-related initiatives, and to prevention of the disease in particular. Separately, the N.I.H. also paused funding for a clinical trial of an H.I.V. vaccine made by Moderna.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and\u00a0log into\u00a0your Times account, or\u00a0subscribe\u00a0for all of The Times.Thank you for your patience while we verify access.Already a subscriber?\u00a0Log in.Want all of The Times?\u00a0Subscribe.<\/p>\n","protected":false},"author":1,"featured_media":28759,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-28757","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lifestyle"],"_links":{"self":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28757","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28757"}],"version-history":[{"count":2,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28757\/revisions"}],"predecessor-version":[{"id":28760,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/posts\/28757\/revisions\/28760"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=\/wp\/v2\/media\/28759"}],"wp:attachment":[{"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28757"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28757"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medexperts.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28757"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}